Welcome to our dedicated page for Diversified Healthcare Tr SEC filings (Ticker: DHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Diversified Healthcare Trust (Nasdaq: DHC), a Maryland real estate investment trust that owns senior living, medical office and life science properties across the United States. Through these filings, investors can review detailed information on DHC’s financial condition, portfolio, capital structure and material events affecting the trust.
Annual reports on Form 10-K and quarterly reports on Form 10-Q contain audited and interim financial statements, segment discussions for the office and senior housing operating portfolios, risk factor disclosures and management’s analysis of results. These documents are central for understanding how DHC’s healthcare real estate assets, including senior living units and medical office and life science properties, contribute to revenue and operating performance.
Current reports on Form 8-K highlight specific events such as the announcement of quarterly financial results, investor presentations, the sale of management agreements for 116 senior living communities to seven different operators, and the issuance and partial redemption of senior secured notes. For example, recent 8-K filings describe DHC’s private offering of 7.250% senior secured notes due 2030, the related redemption of senior secured notes due 2026 and the posting of investor presentations that discuss these transactions.
DHC also has listed debt securities, including 5.625% Senior Notes due 2042 (trading as DHCNI) and 6.25% Senior Notes due 2046 (trading as DHCNL), which are referenced in its filings. Indentures and related agreements filed as exhibits outline covenants that limit additional indebtedness, require certain financial ratios and govern activities of subsidiary guarantors. Investors interested in DHC’s leverage, refinancing activities and covenant structure can analyze these documents for more detail.
On Stock Titan, SEC filings for DHC are updated as they become available from EDGAR. AI-powered tools summarize lengthy reports such as 10-Ks and 10-Qs, highlight key changes from prior periods and explain complex sections in simpler terms. Users can quickly identify items related to senior housing operations, medical office and life science properties, capital recycling, note offerings and redemptions, and other disclosures that shape the risk and return profile of Diversified Healthcare Trust.
The Vanguard Group filed Amendment No. 2 on a Schedule 13G/A reporting its position in Diversified Healthcare Trust common stock. The filing states amount beneficially owned: 0 shares representing 0%. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The disclosure is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Diversified Healthcare Trust is asking shareholders to vote at its virtual 2026 annual meeting on June 10 on three items: elect seven trustees, approve executive compensation on an advisory basis, and ratify Deloitte & Touche as auditor.
The proxy highlights 2025 actions: sale of 69 non-core properties for about $605 million, using proceeds and cash on hand to fully repay 2026 zero coupon senior secured notes, leaving no debt maturities until 2028. The company also transitioned 116 senior housing operating communities to new managers, expects improvements in occupancy, rates and NOI, and reports it was the top-performing U.S. REIT in 2025 with total shareholder return of roughly 113%.
The filing details a seven-member board with five independent trustees, a lead independent trustee role, committee structures, shareholder engagement, and extensive sustainability and SASB-aligned metrics on energy, water, climate risk and tenant engagement, along with trustee compensation and ownership guidelines.
Diversified Healthcare Trust filed a current report stating that it has posted a new investor presentation on its website. The presentation, dated February 24, 2026, is included as Exhibit 99.1 and is furnished as part of the disclosure to provide investors with updated information about the company.
Diversified Healthcare Trust files its 2025 annual report outlining a large U.S. healthcare real estate platform focused on senior living, medical office and life science properties. As of December 31, 2025, it owned 298 properties across 33 states and Washington, D.C., plus interests in two joint ventures.
The joint ventures own about 2.2 million rentable square feet that were 99% leased with a 14.2-year average remaining lease term. DHC emphasizes senior housing demand from an aging U.S. population, selective acquisitions and dispositions, development and repositioning, and extensive use of third-party managers under TRS structures, while highlighting significant regulatory, reimbursement, financing and operational risks.
Diversified Healthcare Trust reported a Q4 2025 net loss of $21.2 million, or $0.09 per share, but significantly stronger cash metrics, including normalized FFO of $21.8 million, or $0.09 per share, and Adjusted EBITDAre of $72.4 million. Same property senior housing operating portfolio (SHOP) cash NOI rose 27.6% year over year to $38.3 million, driven by 82.4% occupancy and a 5.8% increase in average monthly rates. The medical office and life science portfolio generated same property cash NOI of $24.1 million with 94.7% occupancy.
For full year 2025, DHC posted a net loss of $285.9 million, impacted by $165.7 million of impairments and high interest expense, while normalized FFO improved to $64.4 million. Management highlighted approximately $6.3 billion of real estate across 298 properties and noted it fully redeemed its zero‑coupon notes due 2026, reducing net debt to annualized Adjusted EBITDAre to 8.1x. The company issued 2026 guidance calling for NOI of $297–$313 million, Adjusted EBITDAre of $290–$305 million, and normalized FFO of $125–$140 million, with expected SHOP NOI growth of 26%–33%.
Diversified Healthcare Trust reported two key items. First, it incurred an incentive management fee of $17.9 million for the 2025 calendar year under its Business Management Agreement with The RMR Group LLC. This fee is payable in cash by January 30, 2026 and will be recorded as an expense in the company’s financial statements for the year ended December 31, 2025.
Second, on January 9, 2026, the company received a cash dividend of $27.2 million from AlerisLife Inc. in connection with AlerisLife’s sale of all assets and wind-down of its business. Diversified Healthcare Trust expects to receive an additional cash dividend of approximately $3.0 million to $7.0 million upon completion of that wind-down, though the amount or timing may change.
Diversified Healthcare Trust reported that its President, CEO and Director Christopher J. Bilotto purchased 20,000 common shares of beneficial interest on 12/15/2025 at a weighted average price of $4.886 per share, in multiple transactions priced between $4.88 and $4.89.
After these purchases, he beneficially owns 266,284.908 DHC shares directly, which includes 385.018 shares acquired through a dividend reinvestment plan since his last Section 16 filing.
Diversified Healthcare Trust reported Q3 2025 results. Total revenues were $388.706 million, led by resident fees and services of $333.390 million and rental income of $55.316 million. The quarter posted a net loss of $164.040 million (−$0.68 per share), reflecting $93.243 million of impairment charges, interest expense of $48.886 million, and an $11.191 million loss on early debt actions.
Year to date, revenue reached $1.158 billion with a net loss of $264.665 million. The company sold 32 properties for $353.675 million, recording gains of $103.971 million, and classified 50 properties as held for sale. Subsequent to quarter-end, 12 more properties were sold for $42.130 million.
DHC refinanced and reduced near-term debt: it redeemed the entire $380 million 9.75% senior notes due June 2025, issued $375 million of 7.25% senior secured notes due 2030, and partially redeemed senior secured notes due 2026, leaving $334.370 million outstanding. Cash and cash equivalents were $201.371 million. Total assets were $4.684 billion and equity was $1.689 billion as of September 30, 2025.
Diversified Healthcare Trust furnished an update on its business by announcing financial results for the quarter ended September 30, 2025. The company provided a summary press release and a detailed earnings presentation to accompany the results, making them available as Exhibits 99.1 and 99.2. This 8‑K is limited to distributing those materials and does not itself include the underlying figures.